NEW YORK, April 19, 2021 /PRNewswire/ — Thorne HealthTech, Inc. announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the «SEC») relating to a potential initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The initial public offering is expected to take place after the SEC completes its review process, subject to market and other conditions.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended (the «Securities Act»). This press release is being issued in accordance with Rule 135 under the Securities Act.
About Thorne HealthTech
Thorne HealthTech is a leader in developing the world’s most innovative solutions for a personalized approach to health and wellbeing. Thorne HealthTech is a science-driven wellness company that is utilizing testing and data to create improved product efficacy and deliver personalized solutions to consumers, health professionals, and corporations. Thorne HealthTech’s unique, vertically integrated brands, Thorne and Onegevity, provide insights and personalized data, products, and services that help individuals take a proactive and actionable approach to improve and maintain their health over a lifetime.
View original content to download multimedia:http://www.prnewswire.com/news-releases/thorne-confidentially-submits-draft-registration-statement-301271916.html
SOURCE Thorne HealthTech